Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1997

View Archived Issues

Chemoprotective properties of lisofylline reported

Clinical progress for Kirin's calcimimetic compound reported

Patient enrollment completed for ARDS phase Ib trial

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Plant-based estrogen prevents osteoporosis safely and effectively

More on protein farnesyltransferase inhibitors from Merck & Co.

U. of Florida prepares new metal chelators

Antidiabetic agents under development at Takeda

Boehringer Mannheim describes antiplatelet agents

Several series of integrin antagonists prepared at Searle

Potent, broad-spectrum carbapenem discovered at Fujisawa

Promising results reported from rhATIII trial

Parke-Davis identifies selective FGF receptor tyrosine kinase inhibitor

Verapamil derivative from Toa Eiyo with potential in supraventricular tachycardia

FDA approves Nutropin for GH deficiency in adults

Pentose receives U.S. and European patent allowances for Papirine compounds

Genzyme General seeks U.S. and European approval for Thyrogen

Naratriptan acts through 5-HT1B/1D receptors and accesses the CNS

Daiichi's Floxin receives FDA approval

Italian launch for Alzheimer's disease treatment

First biologic approved for treatment of diabetic foot ulcers

Behavioral effects of novel mGluR agonist in rats

AEterna's psoriasis agent moves to phase I/II in Canada

Animal study indicates potential of GAT inhibitors for anxiety

Hyal discontinues development of osteoarthritis drug

FDA issues health advisory for anticoagulants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...